Should This Patient Receive an Antidepressant?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

Abstract

Depression is a major public health problem and a common cause of disability. To help physicians choose among available treatment options, the American College of Physicians recently issued a guideline titled "Nonpharmacologic Versus Pharmacologic Treatment of Adult Patients with Major Depressive Disorder." The evidence review done for the guideline found no statistically significant difference in the efficacy of second-generation antidepressants (SGAs) versus most other treatments for this disorder. However, rates of adverse events and discontinuation were generally higher in patients treated with SGAs. This Beyond the Guidelines reviews the guideline and includes a discussion between 2 experts on how they would apply it to a 64-year-old man with depression who is reluctant to begin medication. They review the data on which the guideline is based, discuss the limitations of applying the data to real-world settings, review how they would incorporate patient preferences when making treatment decisions, and outline options for patients in whom first-line therapy has failed.

• Authors: Risa B Burns, Gerald W Smetana, Roscoe Brady
• Journal: Annals of internal medicine (Ann Intern Med) Vol. 167 Issue 3 Pg. 192-199 (08 01 2017) ISSN: 1539-3704 [Electronic] United States
• PMID: 28761956 (Publication Type: Clinical Conference)

Chemical References

• Antidepressive Agents, Second-Generation

Topics

• Antidepressive Agents, Second-Generation (adverse effects, therapeutic use)
• Cognitive Behavioral Therapy
• Comparative Effectiveness Research
• Complementary Therapies
• Depressive Disorder (diagnosis, drug therapy, therapy)
• Evidence-Based Medicine
• Humans
• Male
• Middle Aged
• Psychotherapy